Published in Prenat Diagn on April 01, 2010
Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn (2012) 1.88
Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA (2011) 1.59
Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol (2014) 1.44
Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Res Notes (2012) 0.86
Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy. PLoS One (2013) 0.80
Diagnosis for choroideremia in a large Chinese pedigree by next‑generation sequencing (NGS) and non‑invasive prenatal testing (NIPT). Mol Med Rep (2017) 0.75
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet (1998) 6.88
PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet (1997) 1.84
Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol (1995) 1.50
Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update (2004) 1.43
Cell-free fetal DNA in maternal circulation after amniocentesis. Clin Chem (2003) 1.30
Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem (2004) 1.23
Maternal plasma fetal DNA as a marker for preterm labour. Lancet (1998) 1.16
Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod (2003) 1.10
Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol (2004) 1.01
Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci (2004) 0.96
Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy. Fertil Steril (2004) 0.94
Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels. Prenat Diagn (2008) 0.86
Recent developments in fetal DNA in maternal plasma. Ann N Y Acad Sci (2004) 0.86
Circulating cell-free fetal nucleic acid analysis may be a novel marker of fetomaternal hemorrhage after elective first-trimester termination of pregnancy. Ann N Y Acad Sci (2004) 0.83
The relation between maternal serum alpha-fetoprotein levels and fetomaternal haemorrhage. Br J Obstet Gynaecol (1979) 0.81
Changes of cell-free fetal DNA in maternal plasma after elective termination of pregnancy. Clin Chem (2004) 0.81
Sex-determining region Y levels in maternal plasma: Evaluation in abnormal pregnancy. J Obstet Gynaecol Res (2004) 0.80
Origin of amniocentesis-induced rises of alpha-fetoprotein concentrations in maternal serum. Br J Obstet Gynaecol (1980) 0.79
Detection and measurement of fetomaternal haemorrhage: serum alpha-fetoprotein and the Kleihauer technique. Br Med J (1977) 0.78
Fetomaternal hemorrhage in relation to chorionic villus sampling revisited. Prenat Diagn (2006) 0.78
Genetic amniocentesis: significance of intraamniotic bleeding and placental location. Obstet Gynecol (1985) 0.78
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99
First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med (2005) 4.89
Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE. Nucleic Acids Res (2003) 4.29
GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics (2002) 4.24
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol (2004) 4.10
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Assisted reproductive technology and pregnancy outcome. Obstet Gynecol (2005) 2.77
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Transfer of fetal cells with multilineage potential to maternal tissue. JAMA (2004) 2.72
Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65
Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol (2008) 2.52
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol (2002) 2.25
The homocysteine hypothesis of depression. Am J Psychiatry (2007) 2.17
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis (2006) 2.16
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
Intact fetal cells in maternal plasma: are they really there? Lancet (2003) 2.09
The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum (2003) 2.03
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
First-trimester cystic hygroma: relationship of nuchal translucency thickness and outcomes. Obstet Gynecol (2012) 2.00
Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet (2013) 1.99
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88
Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa. Am J Hum Genet (2011) 1.85
Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics (2010) 1.82
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis (2008) 1.82
Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A (2009) 1.81
Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers (2009) 1.77
Quantification of green fluorescent protein by in vivo imaging, PCR, and flow cytometry: comparison of transgenic strains and relevance for fetal cell microchimerism. Cytometry A (2008) 1.72
Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol (2005) 1.68
Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ (2007) 1.67
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol (2004) 1.67
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology (2010) 1.60
Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA (2011) 1.59
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int (2010) 1.55
Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Community Genet (2011) 1.55
Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem (2013) 1.55
Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. Am J Kidney Dis (2007) 1.53
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry (2006) 1.50
First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol (2004) 1.47
Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol (2007) 1.46
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis (2008) 1.46
Contingent screening for Down syndrome--results from the FaSTER trial. Prenat Diagn (2008) 1.45
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med (2009) 1.44
Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients. Clin J Am Soc Nephrol (2013) 1.44
Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol (2011) 1.43
Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med (2009) 1.43
Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol (2006) 1.43
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ (2013) 1.43
Lessons learned from the introduction of personalized genotyping into a medical school curriculum. Genet Med (2011) 1.41
Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more. Heart Rhythm (2006) 1.40
Urinary diversion/reconstruction for cases of catheter intolerant secondary progressive multiple sclerosis with refractory urinary symptoms. J Urol (2011) 1.40
Genetic considerations in the prenatal diagnosis of overgrowth syndromes. Prenat Diagn (2009) 1.38
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD. Circ Cardiovasc Genet (2015) 1.38
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr (2012) 1.38
Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol (2005) 1.37
Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA (2005) 1.36
Serum bicarbonate and long-term outcomes in CKD. Am J Kidney Dis (2010) 1.35
Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.35
Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology (2013) 1.34
Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet (2010) 1.32
Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.32
Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol (2005) 1.29
Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn (2009) 1.29
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol (2006) 1.29
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol (2005) 1.28
Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab (2013) 1.28
Neonatal salivary analysis reveals global developmental gene expression changes in the premature infant. Clin Chem (2009) 1.27
Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol (2006) 1.27